Other Archives - Biocryst

Final results from ALPHA-STAR, a Phase 1b/2 Trial of Navenibart in Hereditary Angioedema

View Article

biocryst

February 18, 2026

Hereditary Angioedema (HAE)
Significant response to berotralstat in 3 patients with hereditary angioedema of unknown origin

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
A Retrospective Analysis of Long-Term Prophylaxis with Berotralstat in Patients with Hereditary Angioedema and Acquired C1-Inhibitor Deficiency-Real-World Data

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
Berotralstat for hereditary angioedema with C1 inhibitor deficiency: a practical guide for clinicians

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
Diagnosis and Management of Anabolic Androgenic Steroid Use

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
Optimal Management of Hereditary Angioedema: Shared Decision-Making

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
Definition, acronyms, nomenclature, and classification of angioedema: AAAAI, ACAAI, ACARE, and APAACI DANCE consensus

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
Development and validation of a US quality of life instrument for hereditary angioedema due to C1 inhibitor deficiency

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)